A citation-based method for searching scientific literature

Paul T C Wan, Mathew J Garnett, S Mark Roe, Sharlene Lee, Dan Niculescu-Duvaz, Valerie M Good, C Michael Jones, Christopher J Marshall, Caroline J Springer, David Barford, Richard Marais. Cell 2004
Times Cited: 2011



Keith T Flaherty, Caroline Robert, Peter Hersey, Paul Nathan, Claus Garbe, Mohammed Milhem, Lev V Demidov, Jessica C Hassel, Piotr Rutkowski, Peter Mohr, Reinhard Dummer, Uwe Trefzer, James M G Larkin, Jochen Utikal, Brigitte Dreno, Marta Nyakas, Mark R Middleton, J├╝rgen C Becker, Michelle Casey, Laurie J Sherman, Frank S Wu, Daniele Ouellet, Anne-Marie Martin, Kiran Patel, Dirk Schadendorf. N Engl J Med 2012
Times Cited: 1845




List of shared articles



Times cited

Clinical Characteristics, Co-Mutations, and Treatment Outcomes in Advanced Non-Small-Cell Lung Cancer Patients With the BRAF-V600E Mutation.
Jingjing Qu, Qian Shen, Yuping Li, Farhin Shaheed Kalyani, Li Liu, Jianya Zhou, Jianying Zhou. Front Oncol 2022
0

RAS pathway regulation in melanoma.
Amira Al Mahi, Julien Ablain. Dis Model Mech 2022
1

Regulation of LncRNAs in Melanoma and Their Functional Roles in the Metastatic Process.
Marine Melixetian, Pier Giuseppe Pelicci, Luisa Lanfrancone. Cells 2022
3

Prevalence of class I-III BRAF mutations among 114,662 cancer patients in a large genomic database.
Jeff Owsley, Matthew K Stein, Jason Porter, Gino K In, Mohamed Salem, Steven O'Day, Andrew Elliott, Kelsey Poorman, Geoffrey Gibney, Ari VanderWalde. Exp Biol Med (Maywood) 2021
7


Autophagy Inhibition in BRAF-Driven Cancers.
Mona Foth, Martin McMahon. Cancers (Basel) 2021
3

Immunomodulatory Properties of BRAF and MEK Inhibitors Used for Melanoma Therapy-Paradoxical ERK Activation and Beyond.
Thomas Jung, Maximilian Haist, Michael Kuske, Stephan Grabbe, Matthias Bros. Int J Mol Sci 2021
4